Used primarily in pharmaceutical research as a synthetic intermediate for central nervous system (CNS) active compounds. Shows potential in the development of dopamine and norepinephrine reuptake inhibitors, making it relevant for studying antidepressants and cognitive enhancers. Also explored in the synthesis of novel pyrrolidine-based receptor ligands for neurological disorders. Its structural features support binding affinity and selectivity in neurochemical pathways. Limited use outside research due to lack of approved therapeutic products containing this core structure.